Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-02-20 @ 10:46 PM
Study NCT ID:
NCT02624492
Status:
COMPLETED
Last Update Posted:
2019-06-17
First Post:
2015-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-04
First Submit QC Date:
None
Study First Post Date:
2015-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-13
Results First Submit QC Date:
None
Results First Post Date:
2019-06-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-13
Last Update Post Date:
2019-06-17
Last Update Post Date Type:
ACTUAL